Merck & Co Digital Transformation Strategy Analysis Report 2025: Accelerators, Innovation Programs, Incubators, ICT, Technology Initiatives, Partnerships, Investments, Acquisitions, Network Map

Dublin, Feb. 25, 2026 (GLOBE NEWSWIRE) -- The "Enterprise Tech Ecosystem Series: Merck & Co., Inc. 2025" company profile has been added to ResearchAndMarkets.com's offering.

The report provides insights into company's tech activities, including its digital transformation strategies, its innovation programs, and its technology initiatives.

Merck & Co Inc (Merck) is a biopharmaceutical company that discovers, develops, manufactures, and markets medicines, vaccines, biologic therapies, and animal health products.

The company offers prescription medicines under the therapy areas of oncology, vaccines, infectious diseases, cardio-metabolic disorders, immunology, neuroscience, and ophthalmology. It also offers a wide range of veterinary pharmaceuticals; vaccines; health management solutions and services; and identification, traceability, and monitoring products.

Merck's products are provided to drug wholesalers, retailers, hospitals, government agencies, health maintenance organizations, pharmacy benefit managers, other institutions, veterinarians, distributors, animal producers, farmers, and pet owners. It operates manufacturing facilities in North America, South America, Western Europe, Africa, and Asia. Merck is headquartered in Rahway, New Jersey, the US.

The report provides information and insights into Merck's tech activities, including:

Reasons to Buy

Key Topics Covered:

Companies Featured

For more information about this company profile visit https://www.researchandmarkets.com/r/b96loe

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.